What Daleron C Treats: Main Uses and Benefits

---

The combination preparation is used to provide symptomatic relief across domains involving heightened physiological activity and physical discomfort. The core analgesic component is commonly used to ease various aches and reduce fever.

The medication is generally applied in conditions characterized by periods of heightened symptoms, such as seasonal cold and flu, and for episodic or recurrent manifestations of discomfort. It is relevant for easing localized and widespread aches, including headache, toothache, menstrual cramps, and muscle or joint pain, while also being relevant for easing elevated body temperature (fever).

“This preparation supports patients during difficult episodes by easing distress and is commonly applied when short-term symptomatic assistance is needed.”

By addressing these symptom clusters that interfere with functional stability, the preparation contributes to improved comfort and helps reduce the overall disruptive impact of symptoms. This dual approach provides supportive relief during acute symptomatic phases.

Quick Fact: Relief for Fever and Pain The preparation is primarily used for managing mild to moderate pain and reducing high fever, which are symptoms where short-term symptomatic assistance is often needed.

Regulatory References

1. NIH MedlinePlus overview of Acetaminophen uses

Official Eligibility and Contraindications

Daleron C (containing Paracetamol and Ascorbic Acid) is suitable for use by Adults and adolescents above the age of 10 or 16 years, depending on the specific national product labeling. Certain individuals and patient groups are strictly advised not to use this medicine or must use it with caution based on regulatory documents.

Eligibility Classification	Population Restriction
Contraindicated	Individuals with hypersensitivity to Paracetamol, Ascorbic Acid, or any excipients. Patients with severe hepatic impairment or severe active liver disease.
Not Recommended	Children under the age of 10 or 16 years (varies by formulation/region).
Caution/Special Consideration	Patients with severe renal impairment or severe hepatic impairment. Individuals with non-cirrhotic alcoholic liver disease or conditions causing glutathione deficiency (e.g., severe malnutrition, chronic alcoholism) are at higher risk of overdose complications. Patients on a sodium-restricted diet or those predisposed to renal stones (due to the Ascorbic Acid component) should use with caution.
Pregnancy/Lactation	Paracetamol can be used during pregnancy if clinically necessary, but it should be used at the lowest effective dose and for the shortest duration possible. Use during lactation requires medical consultation.

The regulatory profile defines strict exclusions for those with severe liver dysfunction and known allergies, while flagging several conditions that necessitate professional advice and caution due to increased risk of toxicity or drug-related complications.

The official regulatory profile for Daleron C defines specific interaction-related constraints and cautions, primarily involving its two active components. Co-administration is strictly restricted with any other products containing acetaminophen due to the formal risk of severe liver injury. This restriction is also extended to individuals with severe hepatic impairment or active liver disease. Furthermore, the risk of hepatotoxicity is formally noted to be substantially increased when acetaminophen is used in combination with chronic, excessive alcohol consumption (defined as three or more drinks daily).

In terms of drug-drug interactions, oral anticoagulants like Warfarin require caution, as prolonged regular daily use of the acetaminophen component may enhance the anticoagulant effect and increase the risk of bleeding (Pharmacodynamic Reinforcement). The speed of paracetamol absorption is accelerated by Metoclopramide and Domperidone, while it is reduced by Cholestyramine.

The Ascorbic Acid component introduces chemical interactions: it may increase the absorption of elemental iron and can decrease the activities of certain antibiotics (e.g., Doxycycline). High doses of Ascorbic Acid can also prolong the presence of paracetamol in the blood. Finally, population-specific notes define that the risk of High Anion Gap Metabolic Acidosis (HAGMA) with Flucloxacillin is amplified in patients with chronic alcoholism or renal impairment.

Central Prostaglandin Synthesis Modulation

The mechanism of action primarily involves modulation of the cyclooxygenase (COX) enzyme system in the central nervous system (CNS). The compound influences this enzyme system to limit the central synthesis of prostaglandins, which are lipid mediators critical for regulating the thermal set point and central nociceptive signaling. This pathway adjustment contributes to thermoregulatory modulation and altered central nociceptive transmission.

---

Descending Serotonergic Pathway Engagement

Another domain involves the direct or indirect modulation of central descending pain inhibitory pathways that rely on the neurotransmitter serotonin. Stimulation of these pathways within the spinal cord modifies descending modulatory signaling, which influences subsequent nociceptive processing at the central level.

---

Endocannabinoid System Interaction

Mechanistic studies also indicate activity involving the drug's metabolites and elements of the endocannabinoid system, including specific transient receptor potential (TRPV1) channels. This interaction initiates signaling sequences that modify glutamatergic transmission in the spinal cord, thereby influencing the magnitude of mediator activity and modulating afferent nociceptive input.

Official Administration and Dosage Guidelines

Daleron C is formulated as a powder for oral solution and its administration is governed by labeling. The medicine must be consumed via the oral route and requires preparation immediately before ingestion. The content of one sachet must be fully dissolved by stirring it into a specified quantity of hot water or tea, creating a solution that is taken orally.

The standard dosing regimen is designed for short-term, intermittent use in accordance with guidelines for its active components.

Feature	Official Labeled Instruction
Standard Adult Dose	One sachet per dose, containing 500 mg of Acetaminophen.
Dosing Frequency	The dose may be repeated every 4 to 6 hours as required, adhering to a minimum interval of 4 hours between doses.
Maximum Daily Limit	Administration should not exceed a total of four sachets in any 24-hour period.

Use Constraints and Duration

The usage protocol requires strict dose control and sets time limits for administration. The preparation is intended for short-term use only and should not be administered continuously for more than 3 days for fever or 5 to 7 days for pain. If a dose is missed, instructions advise against taking a double dose to compensate; the user should simply continue with the next scheduled dose.

Specialized instructions exist for certain populations: for adults with renal impairment, the minimum dosing interval is recommended to be extended to 6 hours or longer to ensure appropriate systemic management. The product is generally labeled for adults and adolescents above a certain age (often 16 years), and concurrent use with any other medication containing acetaminophen is prohibited.

Research evidence / Overview of studies for Daleron C

---

Evidence Structure for Acute Febrile Illnesses (Common Cold and Flu)

This section will summarize the types of research, such as Randomized Controlled Trials (RCTs) and systematic reviews, that have examined the effect of the components on symptoms related to common cold, influenza, and fever.

Research for this product has explored the context of symptoms associated with conditions involving periods of heightened symptoms, such as colds and flu. Specifically, studies monitored changes in elevated body temperature and measured patient-reported outcomes describing perceived discomfort like headaches and generalized aches. Findings describe patterns observed in the studies related to the antipyretic component in monitoring changes in fever, and the evaluation of outcomes related to physical discomfort. For the Vitamin C component, research highlights changes measured during the study period related to the overall duration or severity of cold symptoms, though outcomes described in various studies may vary.

What remains uncertain is the need for more comparative evidence that directly assesses this specific two-component combination against the Acetaminophen component alone for cold symptoms. Follow-up durations were limited in many symptom-focused studies, providing insight into immediate relief but offering little information on long-term outcomes following multiple uses.

---

Evidence Structure for Mild to Moderate Pain

This section will outline the structure of evidence, predominantly from RCTs and meta-analyses, that was evaluated in the context of various types of discomfort, including headache, toothache, and muscular pain.

The evidence base for the pain-relief focus includes numerous RCTs and systematic reviews that research examined the Acetaminophen component in many different scenarios. Studies focused on outcomes related to physical discomfort, monitoring changes in pain intensity using standard scales and measuring the duration of observed symptom relief. Evidence for this component contributes to the broader evidence landscape of symptom patterns in these contexts. However, the existing evidence is largely focused on the single analgesic component itself. Furthermore, the follow-up durations were limited to acute pain episodes, providing limited information on chronic or recurrent pain patterns.

---

What Research Still Needs to Be Explored

This concluding section synthesizes the key limitations, inconsistencies, and gaps identified in the current body of evidence.

Several research gaps and limitations were observed across the evidence landscape. One key limitation is that comparative evidence is lacking between this specific combination product and the Acetaminophen component used alone. Research has yet to fully establish the specific measurable contribution of the Vitamin C component to the changes observed in acute symptom trials.

Common questions about Daleron C (FAQ)

---

Q: What is the main difference between Daleron C and regular Daleron tablets?

Official documents classify Daleron C as a combination product for symptomatic relief. It contains two active ingredients: Acetaminophen (Paracetamol) and Ascorbic Acid (Vitamin C), and is typically available as a powder for oral solution. Regular Daleron tablets generally contain the single active ingredient, Acetaminophen, in a tablet form.

---

Q: Does Daleron C contain aspirin or ibuprofen?

No. Official labeling for Daleron C confirms that the active ingredients are Acetaminophen and Ascorbic Acid. The product is classified as a non-opioid analgesic and antipyretic, and it does not contain aspirin or ibuprofen.

---

Q: What symptoms is Daleron C primarily indicated for?

Daleron C is officially indicated for the symptomatic relief of mild to moderate pain and fever that is often associated with common illnesses like colds and flu. This may include symptoms such as headache and general aches.

---

Q: How quickly does Daleron C usually start to work?

The active analgesic component, paracetamol, is described in official drug information as having an onset of action that is generally observed within 30 minutes following oral administration of a solution form. The precise time of onset may vary between patients.

---

Q: What is the expected duration of the pain-relieving effect of Daleron C?

The effects of the active analgesic component are typically described in official documents as lasting approximately four to six hours. This duration is consistent with the minimum interval suggested for repeating the dose.

---

Q: Is Daleron C appropriate for children, and at what age?

Official labeling generally states that Daleron C is suitable for use by adults and adolescents. The product is not recommended for children below the specific age limit defined on the local product label, which often ranges from 10 to 16 years depending on the formulation.

---

Q: Can Daleron C be taken with antibiotics or other common cold medications?

The use of Daleron C with any other medicine containing paracetamol/acetaminophen is strictly prohibited due to the risk of serious liver injury. Interactions with certain specific antibiotics are documented, requiring caution. The requirement for other medications is to review the full list of interactions or consult with a healthcare professional.

---

Q: Does Daleron C contain sugar or other ingredients that are relevant for people with diabetes?

The official product label must list all inactive ingredients, or excipients. Many powder preparations for oral solution contain sugars (such as sucrose or glucose) or artificial sweeteners. This information is relevant for individuals with diabetes or other specific dietary restrictions.

---

Q: Is there a maximum number of days I should use Daleron C without consulting a healthcare provider?

The product is intended for short-term use only. Official usage protocols specify a maximum duration: not more than 3 days for fever or 5 to 7 days for pain. Use that extends beyond these official time limits requires a review by a healthcare professional.

---

Q: What is the evidence regarding paracetamol use and its effectiveness for low back pain?

Official product information primarily indicates the analgesic component for common acute pain, headache, and general muscular pain. While the active ingredient has been examined in the context of various musculoskeletal pains, its effectiveness for specific low back pain is not a primary or universally stated indication on the product label.

---

Q: What is the distinction between Daleron C and an antiviral medicine?

Daleron C is officially classified as an analgesic, an antipyretic, and a vitamin supplement. It is intended solely for symptomatic relief of pain and fever. Regulatory documents confirm that it is not classified as an antiviral medicine and does not target the viral cause of an illness.

---

Q: What is the risk of allergic reactions to Daleron C's ingredients?

Allergic reactions (hypersensitivity) to the active ingredients or excipients are listed as a formal contraindication for use. Regulatory information notes that severe allergic reactions, including severe cutaneous reactions (SCARs) and anaphylactic shock, are possible, though typically classified as rare.

---

Q: Is Daleron C the same as the cold medicine Daleron COLD3?

Daleron C contains only two active ingredients (Acetaminophen and Ascorbic Acid). Multi-component cold preparations, such as Daleron COLD3, typically contain additional active ingredients, such as decongestants or antihistamines, to address a broader range of symptoms. Therefore, the two preparations are compositionally and functionally different.

---

Q: Can Daleron C be used for pain relief other than cold or flu symptoms?

Yes. Official product indications state that the drug provides relief of mild to moderate pain, which is a general category. While often used for cold/flu-related discomfort, official labeling supports its use for other types of acute pain, such as headache, toothache, and menstrual pain.

---

Q: Can taking Daleron C cause drowsiness or affect my ability to drive?

The active ingredients, Acetaminophen and Ascorbic Acid, are not generally associated with causing drowsiness or sedation. Official safety documents for products containing only these components do not typically include warnings about operating machinery or driving.

---

Q: Are there specific types of food or drinks that interact with Daleron C?

Regulatory documents specifically issue a strong warning against the consumption of alcohol due to the increased risk of severe liver damage. No specific non-alcoholic foods or drinks are typically listed as requiring restriction in the official safety information.

---

Q: Does Daleron C interact with caffeine or energy drinks?

Official labeling for Daleron C does not typically list specific interactions with common beverages. However, regulatory documents regarding paracetamol mention that high doses of caffeine can affect how the body processes the medication. Excessive consumption of caffeine from energy drinks or other sources is noted in regulatory information as potentially warranting caution.

---

Q: Is Daleron C suitable for people with high blood pressure?

Unlike cold medicines that contain decongestants, the active ingredients in Daleron C, Acetaminophen and Ascorbic Acid, do not typically have a formal contraindication for uncomplicated high blood pressure. Caution is officially advised for patients with underlying conditions such as severe renal or hepatic impairment.

---

Q: Are there special warnings for older adults taking Daleron C?

While there is no blanket warning for all older adults, official documents advise caution for patients with underlying conditions common in this population. These conditions include severe renal or hepatic impairment, and any condition that puts a person at risk of glutathione depletion.

---

Q: What are the inactive ingredients in Daleron C that users should be aware of?

The official product label provides a complete list of inactive ingredients (excipients) used in the formulation. Individuals with known allergies, intolerances, or specific dietary restrictions may need to review the list of inactive ingredients, which can include coloring agents, sweeteners (e.g., sucrose or aspartame), or preservatives.

---

Q: Does Daleron C affect blood clotting or bruising?

Daleron C itself is not classified as an anticoagulant (blood thinner). However, regulatory documents note that the prolonged, regular daily use of the paracetamol component can enhance the effect of certain oral anticoagulants (like Warfarin), which may increase the risk of bleeding.

---

Q: Can I develop tolerance or dependence on Daleron C?

No. The active ingredients, Acetaminophen and Ascorbic Acid, are not classified as controlled substances under regulatory guidelines. Official documents do not list the risk of developing tolerance or psychological/physical dependence (addiction) with short-term, recommended use.

---

Q: Can Daleron C be used for chronic pain conditions?

The regulatory profile clearly limits the use of this product to a maximum duration of 5 to 7 days for pain. Use for managing chronic, long-term pain conditions would exceed this official time limit and is not supported by the product's official labeling.

---

Q: Does Daleron C affect sleep or cause insomnia?

Official safety documents for products containing only these active ingredients do not typically list insomnia or other sleep disorders as common, recognized side effects. Unlike some cold medicines, it does not contain stimulants.

---

Q: What is meant by the 'systemic' effect of Daleron C?

The term 'systemic' is used in official texts to describe the drug's effect when it acts throughout the entire body by entering the bloodstream. This means the medicine is absorbed and circulated to reduce fever and pain centrally, rather than acting only in the area where it is applied.

Storage and Disposal of Daleron C

Official regulatory documents define strict conditions for storing Daleron C (Paracetamol/Ascorbic Acid Powder) to maintain its stability. The product must be stored in the original packaging to ensure protection from light and moisture.

Storage Requirement	Specification
Temperature Limit	Do not store above 25 °C (or 77 F).
Safety Constraint	Keep out of the sight and reach of children.

Storage environments that are prohibited include refrigeration and freezing. The powder should not be used past the expiry date stated on the carton.

For disposal, do not dispose of this medicine via wastewater or household waste. All unused or expired medicine must be discarded by returning it to a local pharmaceutical take-back scheme or following local regulatory procedures.